Trends of 21-gene recurrence score assay use in older patients with breast cancer

A genetic test for patients with breast cancer that helps to predict the risk of developing metastatic disease and the expected benefits of chemotherapy has been adopted quickly into clinical practice in a study of older patients and it appears to be used consistently within guidelines and equitably across geographic and racial groups, according to a study published online by JAMA Oncology. —> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *